Lanzhou Foci Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.041x

Lanzhou Foci Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Lanzhou Foci Pharmaceutical Co Ltd (002644) has a cash flow conversion efficiency ratio of 0.041x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥75.62 Million ≈ $11.07 Million USD) by net assets (CN¥1.85 Billion ≈ $270.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Lanzhou Foci Pharmaceutical Co Ltd (2007–2024)

Cash flow conversion efficiency of Lanzhou Foci Pharmaceutical Co Ltd from 2007 to 2024. This chart illustrates how Lanzhou Foci Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 002644 share price today for real-time trading data and today's change.

Lanzhou Foci Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Lanzhou Foci Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Lanzhou Foci Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lanzhou Foci Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see 002644 market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
ZJAMP Group Co Ltd SHE:002758	0.073x
MK Restaurant Group Public Company Limited BK:M	0.047x
Skandinaviska Enskilda Banken AB (publ) ST:SEB-C	1.189x
Consensus Cloud Solutions Inc NASDAQ:CCSI	1.226x
Woori Technology Inc KQ:032820	-0.028x
Jilin Liyuan Precision Manufacturing Co Ltd SHE:002501	-0.165x
Vulcan Steel Ltd AU:VSL	0.138x
Nova Technology TWO:6613	-0.028x

Annual Cash Flow Conversion Efficiency for Lanzhou Foci Pharmaceutical Co Ltd (2007–2024)

The table below shows the annual cash flow conversion efficiency of Lanzhou Foci Pharmaceutical Co Ltd from 2007 to 2024. Review Lanzhou Foci Pharmaceutical Co Ltd (002644) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.81 Billion ≈ $265.59 Million	CN¥38.98 Million ≈ $5.70 Million	0.021x	-42.20%
2023-12-31	CN¥1.77 Billion ≈ $258.78 Million	CN¥65.71 Million ≈ $9.62 Million	0.037x	-10.97%
2022-12-31	CN¥1.73 Billion ≈ $253.73 Million	CN¥72.37 Million ≈ $10.59 Million	0.042x	+472.99%
2021-12-31	CN¥1.63 Billion ≈ $238.15 Million	CN¥11.85 Million ≈ $1.73 Million	0.007x	-81.62%
2020-12-31	CN¥1.59 Billion ≈ $232.24 Million	CN¥62.89 Million ≈ $9.20 Million	0.040x	+24.86%
2019-12-31	CN¥1.51 Billion ≈ $220.51 Million	CN¥47.82 Million ≈ $7.00 Million	0.032x	+24.68%
2018-12-31	CN¥1.44 Billion ≈ $210.78 Million	CN¥36.66 Million ≈ $5.36 Million	0.025x	-47.92%
2017-12-31	CN¥1.36 Billion ≈ $198.89 Million	CN¥66.42 Million ≈ $9.72 Million	0.049x	+10.85%
2016-12-31	CN¥1.29 Billion ≈ $188.85 Million	CN¥56.90 Million ≈ $8.33 Million	0.044x	-15.17%
2015-12-31	CN¥1.23 Billion ≈ $180.52 Million	CN¥64.11 Million ≈ $9.38 Million	0.052x	-59.24%
2014-12-31	CN¥735.22 Million ≈ $107.59 Million	CN¥93.75 Million ≈ $13.72 Million	0.128x	+956.24%
2013-12-31	CN¥703.37 Million ≈ $102.93 Million	CN¥-10.47 Million ≈ $-1.53 Million	-0.015x	+8.69%
2012-12-31	CN¥675.53 Million ≈ $98.85 Million	CN¥-11.02 Million ≈ $-1.61 Million	-0.016x	-535.65%
2011-12-31	CN¥648.08 Million ≈ $94.84 Million	CN¥2.43 Million ≈ $355.00K	0.004x	-97.82%
2010-12-31	CN¥326.46 Million ≈ $47.77 Million	CN¥56.18 Million ≈ $8.22 Million	0.172x	+1156.35%
2009-12-31	CN¥252.96 Million ≈ $37.02 Million	CN¥3.46 Million ≈ $507.01K	0.014x	+392.85%
2008-12-31	CN¥216.81 Million ≈ $31.73 Million	CN¥602.56K ≈ $88.17K	0.003x	-99.49%
2007-12-31	CN¥195.20 Million ≈ $28.56 Million	CN¥105.61 Million ≈ $15.45 Million	0.541x	--

About Lanzhou Foci Pharmaceutical Co Ltd

SHE:002644 China Drug Manufacturers - Specialty & Generic

Market Cap

$571.65 Million

CN¥3.91 Billion CNY

Market Cap Rank

#11259 Global

#3097 in China

Share Price

CN¥7.65

Change (1 day)

+0.66%

52-Week Range

CN¥6.81 - CN¥10.02

All Time High

CN¥18.02